For questions, please contact Matthew Wood via email at Matthew.Wood@baystatehealth.org 

Objectives

After participating in this educational activity, attendees should be able to:

1|Identify the definition of cardiac amyloidosis and its pathophysiology.
2|Discuss epidemiology of cardiac amyloidosis and its significance in clinical practice.
3|Recognize “red flags” during history, physical and routine cardiac testing suggestive of cardiac amyloidosis
4|Identify testing required for diagnosis of cardiac amyloidosis.
5|Implement treatment/modify GDMT therapy for patients with cardiac amyloidosis.
6|How/when to refer to Advanced Heart Failure program at Baystate Health

Presenter(s):

Francis Sabas, AGACNP-BC, DNP
Nurse Practitioner
Baystate Health

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Francis SabasSpeakerNo relevant relationships with ineligible companies to discloseNo
Session date: 
07/08/2025 - 6:30pm EDT to 08/06/2025 - 12:00am EDT
Location: 
Virtual-Zoom
Baystate Medical Center
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 ACPE Contact Hours
  • 0.75 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.